WELLS FARGO & COMPANY/MN - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,705
+85.3%
5,721
+3.0%
0.00%
Q2 2023$920
-82.8%
5,555
+1.3%
0.00%
Q1 2023$5,352
-6.0%
5,484
+0.1%
0.00%
Q4 2022$5,695
-18.6%
5,476
+0.2%
0.00%
Q3 2022$7,000
-30.0%
5,464
+0.4%
0.00%
Q2 2022$10,000
-44.4%
5,441
-7.7%
0.00%
Q1 2022$18,000
-10.0%
5,895
+9.3%
0.00%
Q4 2021$20,000
-37.5%
5,394
-11.0%
0.00%
Q3 2021$32,000
+39.1%
6,060
-0.7%
0.00%
Q2 2021$23,000
-98.0%
6,103
-98.7%
0.00%
Q1 2021$1,167,000
+151.5%
454,168
+144.9%
0.00%
Q4 2020$464,000
+14.6%
185,479
-5.2%
0.00%
Q3 2020$405,000
-11.4%
195,696
+32.9%
0.00%
Q2 2020$457,000
+57.0%
147,213
+15.3%
0.00%
Q1 2020$291,000
-12.9%
127,686
+38.2%
0.00%
Q4 2019$334,000
+6.0%
92,418
+0.1%
0.00%
Q3 2019$315,000
-24.8%
92,283
+3.7%
0.00%
Q2 2019$419,000
+32.2%
88,983
-5.8%
0.00%
Q1 2019$317,000
+24.8%
94,503
-0.8%
0.00%
Q4 2018$254,000
-48.9%
95,237
+7.3%
0.00%
Q3 2018$497,000
+2.7%
88,772
-7.0%
0.00%
Q2 2018$484,000
-6.6%
95,446
+25.6%
0.00%
Q1 2018$518,000
-16.9%
75,964
-8.0%
0.00%
Q4 2017$623,000
+493.3%
82,603
+354.8%
0.00%
Q3 2017$105,00018,1640.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 5,628,585$5,853,7285.06%
Aquilo Capital Management, LLC 4,552,876$4,734,9911.78%
BVF INC/IL 5,080,320$5,283,5330.22%
Soleus Capital Management, L.P. 1,000,000$1,040,0000.15%
Cutter & CO Brokerage, Inc. 378,479$393,6180.13%
PLATINUM INVESTMENT MANAGEMENT LTD 1,220,798$1,269,6300.05%
GSA CAPITAL PARTNERS LLP 365,047$3800.05%
Annandale Capital, LLC 67,000$700.02%
WEALTH EFFECTS LLC 21,700$22,5680.01%
Sigma Planning Corp 343,934$357,6910.01%
View complete list of PIERIS PHARMACEUTICALS INC shareholders